Titagarh Rail has secured its first signalling and safety systems order valued at ₹273 crore. This marks a strategic milestone as the company expands beyond rolling stock manufacturing into high-value railway systems. Such diversification improves margin potential and enhances long-term order book quality, especially amid sustained government spending on railway modernization.

Antony Waste Handling’s arm has bagged a ₹1,330 crore collection and transportation contract with a tenure of seven years. Long-duration municipal contracts typically offer predictable cash flows, higher operational leverage, and improved earnings visibility. This development reinforces the company’s leadership position in India’s urban waste management space.

Denta Water has secured four major water infrastructure projects in Karnataka worth over ₹106 crore. With water management emerging as a critical public infrastructure priority, consistent order inflows strengthen the company’s execution pipeline and support revenue growth over the next few quarters.

Bajaj Electricals has announced its entry into solar solutions as a new and additional line of business. This strategic move aligns the company with India’s renewable energy push and opens up cross-selling opportunities across EPC, lighting, and power distribution segments.

GMR Power plans to raise up to ₹1,200 crore through a preferential issue and issuance of warrants. Such capital infusion is generally aimed at strengthening the balance sheet, funding capex, or refinancing existing liabilities, which could improve financial flexibility going forward.

GE Vernova has received a Letter of Award for a 2×500 MW HVDC refurbishment project from Power Grid. This order underscores continued investment in transmission infrastructure and supports the long-term capex theme in power evacuation and grid modernization.

KPI Green Energy’s promoter group has signed an MoU with the Government of Botswana to invest up to ₹36,000 crore. While this represents a long-gestation overseas opportunity, it signals the group’s ambition to scale renewable assets globally, which may influence long-term valuation narratives.

Shree Digvijay Cement has revised the price per share to ₹86.70 for the promoter’s 50% stake sale agreement with IRF. Such repricing often reflects negotiations aligned with market conditions and may keep the stock in focus amid corporate action-led volatility.

TCS disclosed that its AI-related services are generating approximately $1.5 billion on an annualised basis. This reinforces confidence in AI-led revenue growth and positions the company strongly amid global enterprise adoption of generative AI and automation solutions.

HCLTech has bagged a digital transformation deal from ASN Bank, the fourth-largest bank in the Netherlands. European BFSI deal wins add geographical diversification and strengthen the company’s order pipeline in a competitive IT services landscape.

Cyient’s semiconductor arm is set to acquire mixed-signal analog IC maker Kinetic Technologies for $93 million. This acquisition enhances Cyient’s chip design and semiconductor capabilities, aligning it with the global push for supply chain diversification and advanced electronics.

SEBI has revised expense ratios and capped brokerage on mutual fund cash transactions at 6 paise, a decision viewed as better than earlier proposals. This regulatory clarity is seen as positive for AMCs and wealth management platforms, reducing cost pressures and improving business sustainability.

Paytm’s arm has received RBI approval to operate as a payment aggregator for offline and cross-border payments. This approval addresses a key regulatory overhang and could support renewed business momentum in merchant payments and international transaction services.

Mahindra Lifespaces has launched the Mahindra Blossom residential project in Bengaluru with a gross development value of ₹1,900 crore. Bengaluru continues to be a resilient residential market, and new launches support medium-term revenue visibility.

AstraZeneca has received CDSCO approval to import Datopotamab Deruxtecan powder for sale in India. New oncology drug approvals typically support long-term growth prospects, especially in specialized therapy areas.